Increased expression of Apaf-1 and procaspase-3 and the functionality of intrinsic apoptosis apparatus in non-small cell lung carcinoma

Biological Chemistry

Volumn 385, Issue 2, 2004, Pages 153-168

  Křepela, Evžen ^a   Procházka, Jan ^a   Liu, Xiaoyi ^a,b   Fiala, Pavel ^a   Kinkor, Zdeněk ^a  

^a UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

^b Department of Assisted Reproduction   (China)

Author keywords

Apaf 1; Apoptosis; Caspase; Lung cancer; Procaspase

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; DEOXYADENOSINE TRIPHOSPHATE; GRANZYME B; PROCASPASE 3;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; GOLGI COMPLEX; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION;

ACTINS; ADULT; AGED; APOPTOSIS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; CARCINOMA, NON-SMALL-CELL LUNG; CASPASE 3; CASPASE 7; CASPASES; CELL LINE, TUMOR; CYTOCHROMES C; CYTOSOL; DEOXYADENINE NUCLEOTIDES; ENZYME ACTIVATION; ENZYME PRECURSORS; FEMALE; GENE EXPRESSION; GRANZYMES; HUMANS; IMMUNOBLOTTING; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROTEIN BIOSYNTHESIS; PROTEINS; RNA, MESSENGER; SERINE ENDOPEPTIDASES; TRANSCRIPTION, GENETIC;

EID: 1842636513     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2004.034     Document Type: Article

References (65)

1. Acehan, D., Jiang, X., Morgan, D.G., Heuser, J.E., Wang, X., and Akey, C.W. (2002). Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol. Cell 9, 423-432.
2. Allan, L.A., Morrice, N., Brady, S., Magee, G., Pathak, S., and Clarke, P.R. (2003). Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nat. Cell Biol. 5, 647-654.
3. Ambrosini, G., Adida, C., and Altieri, D.C. (1997). A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3, 917-921.
4. Benedict, M.A., Hu, Y.M., Inohara, N., and Núñez, G. (2000). Expression and functional analysis of Apaf-1 isoforms. Extra WD-40 repeat is required for cytochrome c binding and regulated activation of procaspase-9. J. Biol. Chem. 275, 8461-8468.
5. Boatright, K.M., Renatus, M., Scott, F.L., Sperandio, S., Shin, H., Pedersen, I.M., Ricci, J.E., Edris, W.A., Sutherlin, D.P., Green, D.R., and Salvesen, G.S. (2003). A unified model for apical caspase activation. Mol. Cell 11, 529-541.
6. Brognard, J., Clark, A.S., Ni, Y., and Dennis, P.A. (2001). Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res. 61, 3986-3997.
7. Browne, K.A., Blink, E., Sutton, V.R., Froelich, C.J., Jans, D.A., and Trapani, J.A. (1999). Cytosolic delivery of granzyme B by bacterial toxins: Evidence that endosomal disruption, in addition to transmembrane pore formation, is an important function of perforin. Mol. Cell. Biol. 19, 8604-8615.
8. Cardone, M.H., Roy, N., Stennicke, H.R., Salvesen, G.S., Franke, T.F., Stanbridge, E., Frisch, S., and Reed, J.C. (1998). Regulation of cell death protease caspase-9 by phosphorylation. Science 282, 1318-1321.
9. Carter, J., Truong-Tran, A., Grosser, D., Ho, L., Ruffin, R., and Zalewski, P. (2002). Involvement of redox events in caspase activation in zinc-depleted airway epithelial cells. Biochem. Biophys. Res. Commun. 297, 1062-1070.
10. Chalfant, C.E., Rathman, K., Pinkerman, R.L., Wood, R.E., Obeid, L.M., Ogretmen, B., and Hannun, Y.A. (2002). De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. J. Biol. Chem. 277, 12587-12595.
11. Chang, D.W., Ditsworth, D., Liu, H., Srinivasula, S.M., Alnemri, E.S., and Yang, X. (2003). Oligomerization is a general mechanism for the activation of apoptosis initiator and inflammatory procaspases. J. Biol. Chem. 278, 16466-16469.
12. Devarajan, E., Sahin, A.A., Chen, J.S., Krishnamurthy, R.R., Aggarwal, N., Brun, A.M., Sapino, A., Zhang, F., Sharma, D., Yang, X.H. et al. (2002). Down-regulation of caspase 3 in breast cancer: A possible mechanism for chemoresistance. Oncogene 21, 8843-8851.
13. Fernandes-Alnemri, T., Armstrong, R.C., Krebs, J., Srinivasula, S.M., Wang, L., Bullrich, F., Fritz, L.C., Trapani, J.A., Tomaselli, K.J., Litwack, G. et al. (1996). In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA 93, 7464-7469.
14. Fischer, U., Jänicke, R.U., and Schulze-Osthoff, K. (2003). Many cuts to ruin: A comprehensive update of caspase substrates. Cell Death Differ. 10, 76-100.
15. Friedrich, K., Wieder, T., von Haefen, C., Radetzki, S., Jänicke, R., Schulze-Osthoff, K., Dorken, B., and Daniel, P.T. (2001). Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance. Oncogene 20, 2749-2760.
16. Fujikawa, K., Shiraki, K., Sugimoto, K., Ito, T., Yamanaka, T., Takase, K., and Nakano, T. (2000). Reduced expression of ICE/caspase1 and CPP32/caspase3 in human hepatocellular carcinoma. Anticancer Res. 20, 1927-1932.
17. Galvin, J.P., Spaeny-Dekking, L.H.A., Wang, B., Seth, P., Hack, C.E., and Froelich, C.J. (1999). Apoptosis induced by granzyme B-glycosaminoglycan complexes: Implications for granule-mediated apoptosis in vivo. J. Immunol. 162, 5345-5350.
18. Green, D.R., and Evan, G.I. (2002). A matter of life and death. Cancer Cell 1, 19-30.
19. Greenberg, A.K., Hu, J., Basu, S., Hay, J., Reibman, J., Yie, T.A., Tchou-Wong, K.M., Rom, W.N., and Lee, T.C. (2002). Glucocorticoids inhibit lung cancer cell growth through both the extracellular signal-related kinase pathway and cell cycle regulators. Am. J. Respir. Cell Mol. Biol. 27, 320-328.
20. Hanahan, D., and Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100, 57-70.
21. Hancock, K., and Tsang, V.C.W. (1983). India ink staining of proteins on nitrocellulose paper. Anal. Biochem. 133, 157-162.
22. Hoshi, T., Sasano, H., Kato, K., Yabuki, N., Ohara, S., Konno, R., Asaki, S., Toyota, T., Tateno, H., and Nagura, H. (1998). Immunohistochemistry of caspase3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis. Anticancer Res. 18, 4347-4353.
23. Jänicke, R.U., Sprengart, M.L., Wati, M.R., and Porter, A.G. (1998). Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273, 9357-9360.
24. Jiang, X., and Wang, X. (2000). Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J. Biol. Chem. 275, 31199-31203.
25. Kang, B. H., Ko, E., Kwon, O. K., and Choi, K.Y. (2002). The structure of procaspase 6 is similar to that of active mature caspase 6. Biochem. J. 364, 629-634.
26. Kim, K.B., Lotan, R., Yue, P., Sporn, M.B., Suh, N., Gribble, G.W., Honda, T., Wu, G.S., Hong, W.K., and Sun, S.Y. (2002). Identification of a novel synthetic triterpenoid, methyl-2-cyano-3,12-dioxooleana-1,9-dien-28-oate, that potently induces caspase-mediated apoptosis in human lung cancer cells. Mol. Cancer Ther. 1, 177-184.
27. Kischkel, F.C., Lawrence, D.A., Tinel, A., LeBlanc, H., Virmani, A., Schow, P., Gazdar, A., Blenis, J., Arnott, D., and Ashkenazi, A. (2001). Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J. Biol. Chem. 276, 46639-46646.
28. Kolenko, V., Uzzo, R.G., Bukowski, R., Bander, N.H., Novick, A.C., Hsi, E.D., and Finke, J.H. (1999). Dead or dying: Necrosis versus apoptosis in caspase-deficient human renal cell carcinoma. Cancer Res. 59, 2838-2842.
29. Krajewska, M., Wang, H.G., Krajewski, S., Zapata, J.M., Shabaik, A., Gascoyne, R., and Reed, J.C. (1997). Immunohistochemical analysis of in vivo patterns of expression of CPP32 (caspase-3), a cell death protease. Cancer Res. 57, 1605-1613.
30. Křepela, E. (2001). Cysteine proteinases in tumor cell growth and apoptosis. Neoplasma 48, 332-349.
31. Kuwano, K., Hagimoto, N., Maeyama, T., Fujita, M., Yoshimi, M., Inoshima, I., Nakashima, N., Hamada, N., Watanabe, K., and Hara, N. (2002). Mitochondria-mediated apoptosis of lung epithelial cells in idiopathic interstitial pneumonias. Lab. Invest. 82, 1695-1706.
32. Lee, S.H., Kim, H.S., Park, W.S., Kim, S.Y., Lee, K.Y., Kim, S.H., Lee, J.Y., and Yoo, N.J. (2002). Non-small cell lung cancers frequently express phosphorylated Akt; an immunohistochemical study. APMIS 110, 587-592.
33. Liu, X., Li, P., Widlak, P., Zou, H., Luo, X., Garrard, W.T., and Wang, X. (1998). The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proc. Natl. Acad. Sci. USA 95, 8461-8466.
34. -ΔΔCT method. Methods 25, 402-408.
35. Marusawa, H., Matsuzawa, S., Welsh, K., Zou, H., Armstrong, R., Tamm, I., and Reed, J.C. (2003). HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J. 22, 2729-2740.
36. Mukohara, T., Kudoh, S., Yamauchi, S., Kimura, T., Yoshimura, N., Kanazawa, H., Hirata, K., Wanibuchi, H., Fukushima, S., Inoue, K. et al. (2003). Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small-cell lung cancer (NSCLC). Lung Cancer 41, 123-130.
37. Nicholson, D.W. (1999). Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6, 1028-1042.
38. Ogawa, T., Shiga, K., Hashimoto, S., Kobayashi, T., Horii, A., and Furukawa, T. (2003). APAF-1 -ALT, a novel alternative splicing form of APAF-1, potentially causes impeded ability of undergoing DNA damage-induced apoptosis in the LNCaP human prostate cancer cell line. Biochem. Biophys. Res. Commun. 306, 537-543.
39. Palmerini, F., Devilard, E., Jarry, A., Birg, F., and Xerri, L. (2001). Caspase 7 downregulation as an immunohistochemical marker of colonic carcinoma. Hum. Pathol. 32, 461-467.
40. Rodriguez, J., and Lazebnik, Y. (1999). Caspase-9 and Apaf-1 form an active holoenzyme. Gene Dev. 13, 3179-3184.
41. Roy, S., Bayly, C.I., Gareau, Y., Houtzager, V.M., Kargman, S., Keen, S.L., Rowland, K., Seiden, I.M., Thomberry, N.A., and Nicholson, D.W. (2001). Maintenance of caspase-3 proenzyme dormancy by an intrinsic safety catch regulatory tripeptide. Proc. Natl. Acad. Sci. USA 98, 6132-6137.
42. Sahara, S., Aoto, M., Eguchi, Y., Imamoto, N., Yoneda, Y., and Tsujimoto, Y. (1999). Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation. Nature 401, 168-173.
43. Salvesen, G.S., and Duckett, C.S. (2002). IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 3, 401-410.
44. Satoh, K., Kaneko, K., Hirota, M., Toyota, T., and Shimosegawa, T. (2000). The pattern of CPP32/caspase-3 expression reflects the biological behavior of the human pancreatic duct cell tumors. Pancreas 21, 352-357.
45. Schägger, H., and von Jagow, G. (1987). Tricine-sodium dodecylsulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166, 368-379.
46. Seol, D.W., and Billiar, T.R. (1999). A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis. J. Biol. Chem. 274, 2072-2076.
47. Shinoura, N., Muramatsu, Y., Yoshida, Y., Asai, A., Kirino, T., and Hamada, H. (2000). Adenovirus-mediated transfer of caspase-3 with Fas ligand induces drastic apoptosis in U-373MG glioma cells. Exp. Cell Res. 256, 423-433.
48. Shiozaki, E.N., Chai, J., Rigotti, D.J., Riedl, S.J., Li, P., Srinivasula, S.M., Alnemri, E.S., Fairman, R., and Shi, Y. (2003). Mechanism of XIAP-mediated inhibition of caspase-9. Mol. Cell 11, 519-527.
49. Shivapurkar, N., Reddy, J., Matta, H., Sathyanarayana, U.G., Huang, C.X., Toyooka, S., Minna, J.D., Chaudhary, P.M., and Gazdar, A.F. (2002a). Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification. Oncogene 21, 8510-8514.
50. Shivapurkar, N., Toyooka, S., Eby, M.T., Huang, C.X., Sathyanarayana, U.G., Cunningham, H.T., Reddy, J.L., Brambilla, E., Takahashi, T., Minna, J.D., Chaudhary, P.M., and Gazdar, A.F. (2002b). Differential inactivation of caspase-8 in lung cancers. Cancer Biol. Ther. 1, 65-69.
51. Slee, E.A., Harte, M.T., Kluck, R.M., Wolf, B.B., Casiano, C.A., Newmeyer, D.D., Wang, H. G., Reed, J.C., Nicholson, D.W., Alnemri, E.S. et al. (1999). Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144, 281-292.
52. Slee, E.A., Adrain, C., and Martin, S.J. (2001). Executioner caspases-3, -6 and -7 perform distinct, non-redundant, roles during the demolition phase of apoptosis. J. Biol. Chem. 276, 7320-7326.
53. Smith, P.K., Krohn, R.I., Hermanson, G.T., Mallia, A.K., Gartner, F.H., Provenzano, M.D., Fujimoto, E.K., Goeke, N.M., Olson, B.J., and Klenk, D.C. (1985). Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85.
54. Soengas, M.S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J.G., Gerald, W.L., Lazebnik, Y.A. et al. (2001). Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409, 207-211.
55. Srinivasula, S.M., Ahmad, M., Guo, Y., Zhan, Y., Lazebnik, Y., Fernandes-Alnemri, T., and Alnemri, E.S. (1999). Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis. Cancer Res. 59, 999-1002.
56. Stennicke, H.R., and Salvesen, G.S. (2000). Caspases - controlling intracellular signals by protease zymogen activation. Biochim. Biophys. Acta 1477, 299-306.
57. Tamm, I., Wang, Y., Sausville, E., Scudiero, D.A., Vigna, N., Oltersdort, T., and Reed, J.C. (1998). IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 58, 5315-5320.
58. Törmänen-Näpänkangas, U., Soini, Y., Kahlos, K., Kinnula, V., and Pääkkö, P. (2001). Expression of caspases-3, -6 and -8 and their relation to apoptosis in non-small cell lung carcinoma. Int. J. Cancer 93, 192-198.
59. Travis, W.D., Colby, T.V., Corrin, B., Shimosato, Y., and Brambilla, E. (1999). Histological typing of lung and pleural tumours (Berlin, Germany: Springer Verlag).
60. Turunen, N., Pääkkö, P., and Soini, Y. (2000). Apoptosis in gall-bladder carcinomas and dysplasias, its relation to the expression of caspases 3, 6 and 8 and apoptosis regulating proteins bcl-2, mcl-1 and bax. Histol. Histopathol. 15, 53-60.
61. Virkäjarvi, N., Pääkkö, P., and Soini, Y. (1998). Apoptotic index and apoptosis influencing proteins bcl-2, mcl-1, bax and caspases 3, 6 and 8 in pancreatic carcinoma. Histopathology 33, 432-439.
62. Winter, R.N., Kramer, A., Borkowski, A., and Kyprianou, N. (2001). Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res. 61, 1227-1232.
63. Yamabe, K., Shimizu, S., Ito, T., Yoshioka, Y., Nomura, M., Narita, M., Saito, I., Kanegae, Y., and Matsuda, H. (1999). Cancer gene therapy using a pro-apoptotic gene, caspase-3. Gene Ther. 6, 1952-1959.
64. Yang, L., Mashima, T., Sato, S., Mochizuki, M., Sakamoto, H., Yamori, T., Oh-Hara, T., and Tsuruo, T. (2003). Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: Therapeutic effect of a novel polyarginine-conjugated Smac peptide. Cancer Res. 63, 831-837.
65. Zou, H., Yang, R., Hao, J., Wang, J., Sun, C., Fesik, S.W., Wu, J.C., Tomaselli, K.J., and Armstrong, R.C. (2003). Regulation of the Apaf-1/caspase-9 apoptosome by caspase-3 and XIAP. J. Biol. Chem. 278, 8091-8098.